6/3/2019 7:06:05 AM
NanoViricides Receives Favorable FDA Comments On Pre-IND Application For Lead Drug Candidate; Stock Surges
5/13/2019 7:06:54 AM
NanoViricides Announces Completion Of Production Of Lead Candidate For Upcoming GLP Tox Package Studies
4/16/2019 7:06:52 AM
NanoViricides Submits Pre-IND Briefing Documents To FDA
4/9/2019 9:06:33 AM
NanoViricides Provides Update On Pre-IND Meeting With The US FDA, GLP Safety/Toxicology Studies To Begin Soon
3/26/2019 7:04:15 AM
NanoViricides Now Request For "Type B" Pre-IND Meeting With The US FDA For NV-HHV-101
2/26/2019 7:12:26 AM
NanoViricides Reaches An Agreement On Terms Of License For Shingles Virus Drug Development
7/12/2018 7:08:19 AM
NanoViricides Reports That It Is Financially Sound